Back to Search Start Over

Detection of urinary prostate specific antigen by a lateral flow biosensor predicting repeat prostate biopsy outcome.

Authors :
Di Nardo, Fabio
Occhipinti, Sergio
Gontero, Paolo
Cavalera, Simone
Chiarello, Matteo
Baggiani, Claudio
Anfossi, Laura
Source :
Sensors & Actuators B: Chemical. Dec2020, Vol. 325, pN.PAG-N.PAG. 1p.
Publication Year :
2020

Abstract

• Reliable detection of urinary PSA was performed in 10 minutes through a new intuitive lateral flow biosensor. • The lateral flow biosensor showed a limit of detection and a range of quantification of 20 ng mL-1 and 37 – 420 ng mL-1, respectively. • The biosensor showed 92% of accuracy and an almost perfect concordance with the reference ECLIA method. • The biosensors showed acceptable precision with CV % ≤ 13% and diagnostic sensitivity, specificity, positive predictive value and negative predictive value of 100%, 64%, 74% and 100%, respectively. • The uPSA biosensor is a convenient tool to guide clinical decision-making in prostate cancer diagnosis management process. This work describes the development and the application of a lateral flow biosensor for the detection of the prostate specific antigen in urine (uPSA). The biosensor allowed uPSA detection in 10 minutes with a limit of detection and a range of quantification respectively of 20 ng mL-1 and 37 – 420 ng mL-1, showing within and between-day coefficients of variation ≤ 13%. It showed 92% of accuracy and an almost perfect concordance with the reference electrochemiluminescence immunoassay method. The biosensor design provides the disappearance of the Test line signal at the cut-off concentration. This was achieved with a double layer sensing strategy, in which gold nanoparticles were functionalized with Staphylococcal protein A – a mediator – instead of anti-PSA antibody. This strategy allow making a fine-tune on the concentration of the specific antibody, obtaining an on/off switch of the Test line at the cut-off value. The cut-off value was also established in this work, based on the distribution of uPSA levels from 140 patients, who were suspected of prostate cancer and who underwent to first biopsy. The clinical application of the biosensor to predict repeat biopsy outcome in 28 patients showed sensitivity, specificity, positive and negative predictive values of 100%, 64%, 74% and 100%, respectively. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09254005
Volume :
325
Database :
Academic Search Index
Journal :
Sensors & Actuators B: Chemical
Publication Type :
Academic Journal
Accession number :
146477746
Full Text :
https://doi.org/10.1016/j.snb.2020.128812